Influence of Age on Tumour Grade and Myometrial Invasion in Endometrial Cancer: Assessment by Magnetic Resonance Imaging and Histopathology
Main Article Content
Abstract
Background: Advanced age is a significant risk factor for aggressive Endometrial Cancer (EC). Myometrial invasion must be precisely diagnosed and evaluated preoperatively to make plan of the surgical procedure and optimize the prognosis. Histopathology is the confirmatory investigation to assess depth of myometrial invasion and tumour grade. Aim: The objective was to determine how age affects tumour grade and myometrial invasion in endometrial cancer, as well as to evaluate MRI accuracy in detecting preoperative myometrial invasion. Materials and Methods: This was a part of a large cross-sectional analytical study was conducted from January 2022 to December 2022. Purposive sampling was used to include 50 referred patients with biopsy-confirmed endometrial cancer in the Department of Gynaecological Oncology of BSMMU and NICRH. All patients provided written informed consent for the collection and processing of their data for scientific purposes and the patients were informed about the goal of the study. MRI was used to assess myometrial invasion preoperatively. Results: A total of 52% participants were in 51-60 years age group. The association between age with grade of tumour and deep myometrial invasion were (in MRI and histopatholgy) significantly associated (p<0.05 in patients aged 51-60 years old). MRI findings confirmed 23 (46%) and 27 (54.0%) patients had superficial and deep invasion respectively. The sensitivity, specificity, accuracy, PPV and NPV of MRI to detect myometrial invasion were 91.3%, 77.8%, 84.0%, 77.8%, and 91.3% respectively. Conclusion: The influence of age on tumour grade and deep myometrial invasion were found significant in patients aged 51 to 60 years, as observed in both MRI and histopathology. Evaluating myometrial invasion is crucial for preoperative staging of EC.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108.
Bourgin C, Saidani M, Poupon C, Cauchois A, Foucher F, Leveque J, et al. Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature. Eur J Surg Oncol. 2016;42:166-175.
Cronin KA, Lake AJ, Scott S, et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer. 2018;124:2785-2800
National Cancer Institute: Surveillance Epidemiology, and End Results Program. Cancer Stat Facts: Uterine Cancer. Available at https://seer.cancer.gov/statfacts/html/corp.html. Accessed August 8, 2024.
Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, et al. Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study. Acta Obstetricia et Gynecologica Scandinavica, (2021)100(3), 444-452. https://doi.org/10.1111/aogs.14015
Yin XH, Jia HY, Shi M, Wu H, Li YM. Magnetic resonance imaging for detection of depth of myometrial invasion and cervical invasion in patients with endometrial carcinoma. Int J Clin Exp Med. 2015;8(10):19501-19505. Published 2015 Oct 15.
Pati SK, Mondal K, Bodhey NK, Bagde N, Gupta RK, Shukla A. Role of Multiparametric MRI in the Preoperative Evaluation of Endometrial Carcinoma: A Cross-Sectional Study. Cureus. 2024 Jul 21;
Raja S, Sharma PK, Sakthi Ganesh Subramonian, Chakradhar Ravipati, Natarajan P. Enhancing Preoperative Assessment of Endometrial Cancer: The Role of Diffusion-Weighted Magnetic Resonance Imaging in Evaluating Myometrial Invasion. Cureus. 2024 Jun 10; doi
Deng Y, Zhao T, Zhang J, Dai Q, & Yan B. Development of a nomogram based on whole-tumor multiparametric MRI histogram analysis to predict deep myometrial invasion in stage I endometrioid endometrial carcinoma preoperatively. Acta Radiologica.2024;0(0) https://doi.org/10.1177/02841851241297603
Ning C, Xu Z, Ma F, Zhu Q, Tao X, Luo X, et al. Suspected myometrial invasion on MRI is correlated with worse outcomes of fertility-preserving treatment in young women with endometrial cancer. Holistic Integrative Oncology. 2024 Jun 25;3(1).
Mohamed DM, abo Dewan KAEW and Mera SM. The Diagnostic accuracy of transvaginal ultrasonography, magnetic resonance imaging and diffusion weighted image in female patients with endometrial carcinoma. Alexandria journal of medicine, 2018, 54(4), pp.685-691.
Vinay NVP, Mekala IN, Ch Dinesh. Role of transvaginal ultrasonography in assessing depth of myometrial invasion among patients with uterine cancer. J. Evid. Based Med. Healthc. 2020, 7(10), pp. 503-507.
Wong M, Amin T, Thanatsis N, Naftalin J. and Jurkovic D. A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer. Journal of Gynecologic Oncology, 2022, 33(2).
Wakkerman FC, Wu J, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Ludy, et al. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials. The Lancet Oncology [Internet]. 2024 Apr 30 [cited 2024 Dec 20];25(6):779–89. Available from: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00142-6/abstract
LEE M, Heo J, Ahn J, Han KD, Lee YJ, Song YS, et al. Cumulative abdominal obesity exposure and risk of endometrial cancer in young women: a population-based cohort study. Research Square (Research Square). 2024 Oct 16;
Buonomo F, Fabiola G, De Almeida CF, Romano F, Ricci G. Preoperative assessment of myometrial and cervical invasion in endometrial cancer by transvaginal sonography versus magnetic resonance imaging. Ultrasound in Obstetrics & Gynecology 2020; 56 (Suppl. 1): 57–378.
Geshev N, Dimitrov R, Kirkov V, Vodenicharova A, Yanakieva A. and Slavov S. Preoperative ultrasound assessment of myometrial invasion in endometrial cancer and prediction of surgical stage. Biotechnology & Biotechnological Equipment, 2022, 36(1), pp.753-758.